Skip to main content

Table 3 Association of Baseline Blood Biomarkers and δ Changes at 4 Weeks (4 Weeks – Baseline) and Recurrence after 3 Months of Immunotherapy

From: Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies

Biomarker OR (95% CI) N = 48 P Value
WBC 1.18 (1.04, 1.34) 0.011
ANC 1.20 (1.04, 1.38) 0.014
ALC 1.62 (0.75, 3.48) 0.22
AMC 3.11 (0.96, 10,05) 0.059
AEC (Eosinophil) 1.77 (0.42, 7.38) 0.44
Platelets 1.11 (0.90, 1.37) 0.32
ANC/ALC 1.02 (0.96, 1.09) 0.54
M:L ratio 1.02 (0.96, 1.09) 0.52
  1. P-values given is based on logistic regression model